MALIGNANT-MELANOMA - INTERACTION WITH COAGULATION AND FIBRINOLYSIS PATHWAYS INSITU

被引:56
作者
WOJTUKIEWICZ, MZ
ZACHARSKI, LR
MEMOLI, VA
KISIEL, W
KUDRYK, BJ
ROUSSEAU, SM
STUMP, DC
机构
[1] VET ADM MED CTR,WHITE RIVER JCT,VT 05001
[2] DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MED,HANOVER,NH 03756
[3] DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT PATHOL,HANOVER,NH 03756
[4] UNIV NEW MEXICO,SCH MED,DEPT PATHOL,ALBUQUERQUE,NM 87131
[5] NEW YORK BLOOD CTR,PLASMA PROT COAGULAT LAB,NEW YORK,NY 10021
[6] UNIV VERMONT,SCH MED,DEPT MED,BURLINGTON,VT 05405
[7] UNIV VERMONT,SCH MED,DEPT BIOCHEM,BURLINGTON,VT 05405
关键词
Cancer procoagulant; Coagulation; Fibrin; Fibrinolysis; Melanoma;
D O I
10.1093/ajcp/93.4.516
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemical techniques applied to fresh frozen sections of metastatic malignant melanoma tissue revealed abundant fibrinogen (or fibrin I) in perivascular areas throughout the tumor connective tissue stroma. Fibrin was readily detected in a focal distribution in the connective tissue around nodules of viable tumor. Staining for D-dimere of cross-linked fibrin (using an antibody that cross-reacted with fragment D of fibrinogen) coincided with staining for fibrin. Diffuse staining of tumor cell bodies was observed for Factor X, and Factor XIII ('a' subunit) was detected in scattered areas of connective tissue throughout the tumors. Factor VII was not detected, and only rare tumor cells stained for tissue factor. These results support the concept that a tumor cell-associated, thrombin-generating pathway exists in situ in malignant melanoma tissue that includes Factor X but neither tissue factor nor Factor VII. By contrast, tumor cell staining was observed rarely for urokinase and to a variable extent for tissue plasminogen activator.
引用
收藏
页码:516 / 521
页数:6
相关论文
共 39 条
[1]  
AMBRUS CM, 1986, 14TH P INT CANC C BU, P583
[2]  
ASTEDT B, 1986, THROMB HAEMOSTASIS, V56, P63
[3]  
BOUKERCHE H, 1987, THROMB HAEMOSTASIS, V58, P507
[4]  
BRUGGEN J, 1981, CANCER IMMUNOL IMMUN, V10, P121
[5]   THE PLASMIN SYSTEM IN HUMAN ADENOCARCINOMAS AND THEIR METASTASES - A COMPARATIVE IMMUNOFLUORESCENCE STUDY [J].
BURTIN, P ;
CHAVANEL, G ;
ANDREBOUGARAN, J ;
GENTILE, A .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :170-178
[6]   A RANDOMIZED TRIAL OF ANTICOAGULATION WITH WARFARIN AND OF ALTERNATING CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER BY THE CANCER AND LEUKEMIA GROUP-B [J].
CHAHINIAN, AP ;
PROPERT, KJ ;
WARE, JH ;
ZIMMER, B ;
PERRY, MC ;
HIRSH, V ;
SKARIN, A ;
KOPEL, S ;
HOLLAND, JF ;
COMIS, RL ;
GREEN, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :993-1002
[7]  
DODD I, 1986, THROMB HAEMOSTASIS, V55, P94
[8]  
DONATI MB, 1986, CANCER RES, V46, P6471
[9]  
DONATI MB, 1981, RECENT ADV BLOOD COA, V3, P227
[10]   SUNLIGHT AND SKIN-CANCER [J].
FITZPATRICK, TB ;
SOBER, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :818-820